Crescent Biopharma Inc. logo

Crescent Biopharma Inc.

CBIO | NASDAQ
Chart Builder DCF Calculator
$12.95
-$0.53 (-3.93%)
Nov 2, 2026, 1:19 PM ET · Market open
TTM
Period Ending
Q2 2026
Jun 30, 2026
Q1 2026
Mar 31, 2026
Q4 2025
Dec 31, 2025
Q3 2025
Sep 30, 2025
Q2 2025
Jun 30, 2025
Q1 2025
Mar 31, 2025
Q4 2024
Dec 31, 2024
Q3 2024
Sep 30, 2024
Q2 2024
Jun 30, 2024
Q1 2024
Mar 31, 2024
Q4 2023
Dec 31, 2023
Q3 2023
Sep 30, 2023
Q2 2023
Jun 30, 2023
Q1 2023
Mar 31, 2023
Q4 2022
Dec 31, 2022
Q3 2022
Sep 30, 2022
Q2 2022
Jun 30, 2022
Q1 2022
Mar 31, 2022
Q4 2021
Dec 31, 2021
Q3 2021
Sep 30, 2021
Q2 2021
Jun 30, 2021
Q1 2021
Mar 31, 2021
Cash & Equivalents
171.59M 189.16M 213.19M 133.27M 152.65M 5.61M 10.72M 14.39M 22.39M 31.28M 41.79M 49.41M 58.04M 65M 47.87M 51.62M 60.24M 76.52M 90.25M 101.92M 118.85M 132.47M
Short-Term Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Long-Term Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Long-Term Assets
1.61M 1.27M 1.32M 1.36M 1.41M n/a n/a 52.32K 137.11K 339.26K 757.91K 102.32K 102.32K 102.32K 344.71K 860.12K 2.27M 2.27M 1.61M 1.61M 1.61M 1.61M
Receivables
n/a n/a 18M n/a n/a n/a 136.58K 50.26K 76.71K 109.95K 175.82K 188.95K 215.37K 234.11K 144.02K 90.33K 120.87K 4.78K 1.35K 1.44K 1.66K 444.57K
Inventory
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Current Assets
2.17M 1.37M 1.28M 1.3M 1.58M 78.76K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Total Current Assets
179.01M 195.56M 236.66M 134.56M 154.23M 5.99M 11.09M 15.65M 23.86M 33.27M 43.79M 52.01M 60.37M 68.09M 50.71M 53.85M 61.26M 77.46M 90.79M 104.13M 120.31M 133.71M
Property-Plant & Equipment
2.15M 2.3M 2.32M 2.35M 1.8M n/a n/a n/a 424.21K 598.26K 767.83K 1.09M 1.35M 732.8K 751.17K 1.25M 1.51M 1.73M 1.95M 2.2M 2.45M 2.7M
Goodwill & Intangibles
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Total Long-Term Assets
3.75M 3.57M 3.64M 3.71M 3.21M n/a n/a 52.32K 561.31K 937.52K 1.53M 1.19M 1.45M 835.12K 1.1M 2.11M 3.78M 4M 3.56M 3.81M 4.06M 4.31M
Total Assets
182.76M 199.13M 240.29M 138.27M 157.43M 5.99M 11.09M 15.7M 24.42M 34.2M 45.32M 53.2M 61.82M 68.92M 51.81M 55.96M 65.04M 81.46M 94.35M 107.94M 124.38M 138.02M
Account Payables
2.54M 1.19M 10M 2.56M 1.65M 148.26K 1.38M 1.01M 950.76K 755.53K 868.12K 329.89K 241.49K 480.15K 970.19K 852.13K 1.27M 2.28M 2.11M 1.39M 1.17M 2.14M
Deferred Revenue
3.12M 3.12M 4.16M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Short-Term Debt
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Current Liabilities
8.37M 6.82M 10.12M 4.84M 3.66M 1.68M 3.49M 1.82M 545.55K 1.23M 2.96M 2.4M 2.57M 2M 2.97M 2.16M 2.4M 1.62M 2.5M 2.34M 2.79M 2.08M
Total Current Liabilities
18.54M 14.19M 36.07M 20.3M 16.75M 2.62M 5.78M 4.32M 4.36M 5.29M 6.84M 6.39M 6.57M 6.74M 8.88M 7.75M 8.94M 12.78M 11.82M 9.66M 10.25M 10.84M
Long-Term Debt
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Long-Term Liabilities
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 538.59K 408.32K 373.91K
Total Long-Term Liabilities
966K 1.09M 1.21M 1.32M 1.43M n/a n/a n/a n/a n/a 66.84K 262.13K 448.78K n/a n/a 95.61K 378.79K 651.79K 918.61K 1.72M 1.84M 2.05M
Total Liabilities
19.5M 15.28M 37.28M 21.63M 18.18M 2.62M 5.78M 4.32M 4.36M 5.29M 6.9M 6.65M 7.02M 6.74M 8.88M 7.84M 9.32M 13.43M 12.74M 11.38M 12.09M 12.9M
Total Debt
1.44M 1.54M 1.64M 1.74M 1.64M n/a 66.84K 262.13K 448.78K 630.83K 808.4K 1.01M 1.27M 651.73K 918.56K 1.18M 1.43M 1.68M 1.92M 2.15M 2.38M 2.6M
Book Value
163.26M 183.85M 203.01M 116.64M 139.25M 3.38M 5.31M 11.38M 20.06M 28.91M 38.41M 46.55M 54.8M 62.18M 42.93M 48.12M 55.73M 68.03M 81.6M 96.57M 112.29M 125.12M
Book Value Per Share
5.35 6.05 10.06 7.05 36.10 4.37 8.24 17.64 31.11 44.85 59.66 72.34 85.26 103.03 81.06 91.79 106.34 130 156.89 187.27 217.87 246.81
Common Stock
28K 28K 28K 14K 14K 64.53K 64.48K 64.48K 64.48K 64.45K 64.39K 64.37K 64.31K 64.25K 54.38K 52.42K 52.42K 52.39K 52.31K 51.74K 51.54K 51.54K
Retained Earnings
-219.93M -195.09M -171.81M -79.41M -54.81M -496.71M -494.36M -487.14M -477.32M -467.22M -456.49M -447.41M -438.2M -429.95M -419.59M -409.34M -400.82M -387.55M -372.9M -355.48M -338.14M -323.74M
Comprehensive Income
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Shareholders Equity
163.26M 183.85M 203.01M 116.64M 139.25M 3.38M 5.31M 11.38M 20.06M 28.91M 38.41M 46.55M 54.8M 62.18M 42.93M 48.12M 55.73M 68.03M 81.6M 96.57M 112.29M 125.12M
Total Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.